DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Avastin (Bevacizumab) - Current Clinical Trials


Avastin Related Clinical Trials

MAAM Study: Avastin and Macugen Versus Avastin Versus Macugen [Recruiting]

A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) [Active, not recruiting]

Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma [Active, not recruiting]

A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma [Completed]

A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer [Terminated]

Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy [Active, not recruiting]

Evaluation of Contrast-Enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases [Recruiting]

A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer. [Active, not recruiting]

Phase II Study of Carboplatin and Bevacizumab (Avastin) for ER Neg, PR Neg, and HER2/Neu Neg Metastatic Breast Cancer [Recruiting]

A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. [Active, not recruiting]

Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization [Recruiting]

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma [Suspended]

Combination Therapy for Age-Related Macular Degeneration. [Recruiting]

Systemic Avastin Therapy in Age-Related Macular Degeneration [Recruiting]

An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study [Completed]

The Avastin vs Visudyne for Neovascular AMD Study [Withdrawn]

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer. [Active, not recruiting]

A Study of Avastin (Bevacizumab) in Women With HER2 Negative Metastatic Breast Cancer [Active, not recruiting]

A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma. [Recruiting]

Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions? [Recruiting]

Avastin/Radiation (XRT)/Temozolomide Followed by Avastin/Temozolomide/Topotecan for Glioblastoma [Recruiting]

Neoadjuvant TAC Plus or Minus Bevacizumab(AVF3299) [Recruiting]

Taxotere Plus Bevacizumab (AVF3110) [Recruiting]

Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-Small Cell Cell Lung Cancer [Recruiting]

Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) [Recruiting]

Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Recruiting]

Avastin Plus Rituximab for Patients With B-Cell Non-Hodgkin's Lymphoma [Completed]

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract. [Recruiting]

Study of Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin Versus Pemetrexed + Carboplatin + Bevacizumab + Placebo in Patients With Non-Small Cell Lung Cancer Who Have Not Been Previously Treated With Chemotherapy [Recruiting]

Phase II Study of Bevacizumab (AvastinŽ) in Myelofibrosis [Recruiting]

Bevacizumab and AZD2171 in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma [Recruiting]

Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab) [Recruiting]

Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma [Recruiting]

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer [Recruiting]

Trial of Paclitaxel/Bevacizumab +/- Everolimus for Patients With HER2-Negative Metastatic Breast Cancer [Recruiting]

Bevacizumab and Irinotecan in Treating Patients With Recurrent High-Grade Malignant Glioma That Progressed on Bevacizumab Alone [Recruiting]

LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma [Recruiting]

Intravitreal Bevacizumab for Retinal Disorders [Recruiting]

A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. [Recruiting]

A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer. [Recruiting]

Intravitreal Avastin Versus Intravitreal Avastin and Triamcinolone in Central Retinal Vein Occlusion(CRVO) [Recruiting]

Efficacy Study of AvastinŽ With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer [Recruiting]

Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM) [Recruiting]

A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. [Recruiting]

Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer. [Recruiting]

Avastin for PDR (Proliferative Diabetic Retinopathy) [Recruiting]

Bevacizumab(Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma [Recruiting]

Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma

Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma [Recruiting]

Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Recruiting]

Trial of Avastin and Tarceva for Locally Advanced or Metastatic Non-Squamous Non-Small-Cell Lung Cancer in Previously Treated Patients [Suspended]

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma [Recruiting]

Post-First Progression Use of Bevacizumab in Metastatic Colorectal Cancer (mCRC) [Recruiting]

Avastin and Taxotere for Esophagogastric Cancer [Active, not recruiting]

Bevacizumab in Advanced Hepatocellular Carcinoma [Recruiting]

Safety/Biomarker Study of CNTO 95 and Avastin in Solid Tumors [Recruiting]

Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma [Recruiting]

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver [Recruiting]

Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer [Recruiting]

AMG 102 and Avastin for Recurrent Malignant Glioma [Recruiting]

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone, in Patients With Neovascular Age Related Macular Degeneration (AMD) [Recruiting]

Bevacizumab and Paclitaxel or Bevacizumab, Cyclophosphamide, and Capecitabine as First-Line Therapy in Treating Women With Locally Advanced, Recurrent, or Metastatic Breast Cancer [Recruiting]

Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) [Recruiting]

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM) [Recruiting]

Study of TRC105 Combined With Standard-Dose Bevacizumab for Advanced Solid Tumors for Which Bevacizumab is Indicated [Recruiting]

Intraarterial Cerebral Infusion of Avastin for Vestibular Schwannoma (Acoustic Neuroma) [Recruiting]

Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer [Recruiting]

Avastin in Combo w XRT & Temozolomide , Followed by Avastin, Temozolomide & Irinotecan for GBM & Gliosarcomas [Recruiting]

Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma [Recruiting]

Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma [Recruiting]

Avastin in Combo w Temo for Unresectable or Multifocal GBMs and Gliosarcomas [Recruiting]

Avastin/Docetaxel/Carboplatin in Non-Small Cell Lung Cancer [Recruiting]

Phase II Pilot Study of VisudyneŽ Photodynamic Therapy (PDT) (Low and Very Low Fluence) Combined With Bevacizumab. [Not yet recruiting]

Intraperitoneal Paclitaxel and Carboplatin With IV Avastin Therapy in Patients With Carcinomas of Mullerian Origin [Recruiting]

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC [Recruiting]

Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma [Recruiting]

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix [Recruiting]

Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC [Recruiting]

Avastin, Docetaxel and Androgen Deprivation Followed by Continued Avastin and Androgen Deprivation for Men With a Rising PSA After Local Therapy [Recruiting]

Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction [Recruiting]

Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects [Recruiting]

Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery [Recruiting]

Bevacizumab and Temozolomide Following Radiation and Chemotherapy for Newly Diagnosed Glioblastoma Multiforme [Recruiting]

Q3week Carboplatin With Weekly Abraxaneä And Avastin + Subsequent Dose-Dense Ac With Avastin As Neoadjuvant Therapy In Resectable And Unresectable (Stage Iia-Iiib) Her2-Negative Breast Cancer [Recruiting]

Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer [Recruiting]

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM [Recruiting]

Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy [Recruiting]

A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-Agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain [Recruiting]

Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer [Recruiting]

Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma [Recruiting]

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Recruiting]

Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma [Recruiting]

Irinotecan, Capecitabine and Avastin for Metastatic Colorectal Cancer as Salvage Treatment [Recruiting]

Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma [Recruiting]

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer [Recruiting]

Effect op Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 [Recruiting]

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers [Recruiting]

Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-Related Macular Degeneration [Recruiting]

Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer [Recruiting]

Avastin and Erlotinib as First Line Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer, and Papillary Serous Mullerian Tumors [Recruiting]

Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment [Recruiting]

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015